Cell Therapeutics Inc. (CTIC) Reports In-Line Q4 Loss of $0.20/Sh

February 28, 2013 5:35 PM
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q4 EPS of ($0.20), in-line ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings